Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

N/ACompletedNCT01428739

AHS Cancer Control Alberta8 enrolled

Overview

Correlation between MRS and Tumor Response Therapy in Breast Cancer.

Correlation between MRS (Magnetic Resonance Spectroscopy and Tumor Response to Radiation in Breast Cancer

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Breast Cancer

Interventions

MRSDEVICE

Procedure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histologically confirmed diagnosed Breast cancer * Patient is 18 years or older * Karnofsky performance score \> 70 * No previously irradiated or recurrent breast cancer * No contraindication to MRS/MRI * Signed informed consent.

Locations (1)

Cross Cancer Institute

Edmonton, Alberta, Canada

Outcomes

Primary Outcomes

MRS Correlation with Treatment Response

measuring choline, water and fat levels by proton magnetic resonance spectroscopy in breast tumors in response to treatment

Time frame: Up to One Year

Secondary Outcomes

Correlation with Tumor Stage

Time frame: Up to One year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.